INTRODUCTION
Invariant T-cell receptor ''natural killer T cells'' (iNKT-cells) are a T-cell subset characterized by the expression of a semiinvariant T-cell receptor (TCR) that is typically composed of paired Va24 and Vb11 chains. 1, 2 This TCR recognizes endogenous 3, 4 and exogenous glycolipids presented by CD1d, a major histocompatibility complex-like molecule. 2 It has been demonstrated that iNKT cells modulate adaptive immunity via interactions with myeloid dendritic cells, 5 likely bridging innate and adaptive immunity through signalling lymphocyte activation molecule and cytokine receptors. 2, 3, 6 Although iNKT cells are a rare subpopulation among T cells, they produce key immunomodulatory cytokines upon activation. 3, 7 The iNKT cells can be divided into two functional subsets determined by the expression of CD4.
1 CD4 þ iNKT cells have a T helper type 0 (Th0) profile, generally produce both Th1 and Th2 cytokines upon activation, principally interferon gamma (IFN-g), tumor necrosis factor, interleukin (IL)-4, and IL-10, and are thought to be anti-inflammatory and pro-atopic. By contrast, CD4
À iNKT cells generally have a pure Th1 profile and are thought to be pro-inflammatory. [8] [9] [10] Given that these iNKT-cell subsets are functionally distinct, they likely have key opposing roles in the modulation of adaptive immunity; imbalances between these subsets have been linked to autoimmune diseases. 1, 11 Activated memory CD4 þ T cells are the major reservoir for HIV-1 replication, as these cells express CCR5 and key transcription factors needed for efficient viral entry and transcription. CD4 þ iNKT cells have this activated memory phenotype with CCR5 expression [12] [13] [14] and have been proposed to be susceptible to HIV-1 infection. 13, [15] [16] [17] Blood levels of the CD4 þ subset of iNKT cells are depleted in persons with chronic HIV-1 infection, and this defect has been proposed to contribute to immune dysregulation. 15, [18] [19] [20] Gut-associated lymphoid tissue is the largest compartment of activated T cells in the body [21] [22] [23] and is a key site for initial establishment of HIV-1 infection regardless of route of transmission, as well as being a reservoir for chronic infection. 24, 25 Abnormalities in the gut induced directly by HIV-1 infection have been suggested to disrupt immune containment of gut bacterial flora, leading to the systemic immune activation that drives disease progression. 26, 27 Given the proposed consequences of CD4 þ iNKT-cell depletion and abnormal gut immunity in HIV-1 pathogenesis, we have examined the phenotypes and levels of iNKT-cell subsets in the gut and blood compartments of HIV-1-infected and uninfected individuals as potential correlates to the chronic immune activation that drives disease progression.
RESULTS

Sampling protocol and clinical status of study subjects
All subjects were confirmed by pre-screening to have quantifiable iNKT cells in the blood (X0.002% of peripheral blood mononuclear cells, Supplementary Figure S1 online) before enrollment; of the 27 pre-screened volunteers, two did not meet this threshold and were excluded. The enrolled participants were 25 Caucasian men, including 18 with chronic HIV-1 infection who were self-reported as untreated with antiviral medications and 7 control men who were HIV-1-uninfected (Supplementary Table S1 online). Median ages were 45 years (range 24-63 years) for the HIV-1-infected group and 37 years (range 21-50 years) for the control group (P ¼ 0.067). Viremia in the infected men ranged from o50 to 68,000 RNA copies per ml of plasma, and peripheral blood CD4 þ T-cell counts ranged from 196 to 911 cells per ml. Each participant underwent two bi-weekly visits for phlebotomy and sigmoid colonic biopsies. Data from both visits were averaged.
The gut mucosa normally is enriched for CD4 þ T cells and is a pro-inflammatory environment compared with peripheral blood
The T-lymphocyte populations in the peripheral blood and sigmoid gut mucosa were compared in the control HIV-1-uninfected group (Figure 1) . Overall, the gut mucosa was relatively higher in the percentage of CD4 þ T cells and lower in Figure 1g ,h), additionally demonstrating a more pro-inflammatory cytokine milieu in the gut compartment. There was no consistent pattern for IL-4 production by gut vs. blood CD4 þ T cells (Figure 1i) . Overall, these data confirm that the gut is normally a highly immune-activated proinflammatory environment, in agreement with previous reports.
The gut mucosa normally is enriched for activated CD4 þ iNKT cells compared with peripheral blood Regulatory iNKT cells were assessed in the gut and blood compartments of the control persons. Within the total CD3 þ T-cell population, there were higher frequencies of total iNKT cells in the gut compared with the blood in six of the seven subjects, although this trend was insignificant due to the outlier (Figure 2a) . Examining CD4 þ and CD4 À iNKT-cell subsets, CD4 þ iNKT cells were more frequent in the gut compared with blood (P ¼ 0.048, Figure 2b ), while the CD4 À subset was similar between the compartments (Figure 2c) . Activation marker analysis of total iNKT cells in both the compartments demonstrated significantly higher percentages of HLA-DR (P ¼ 0.018, Figure 2d ) on the total iNKT population in the gut compared with blood. Percentages of total iNKT cells expressing CCR5 were higher in the gut for five of the seven subjects, although not statistically significant (P ¼ 0.085, Figure 2g ). These differences in activation were more þ T lymphocyte population (data not shown). Altogether, these results suggest that increased frequency and activation of CD4 þ iNKT cells have a counterbalancing role in the inflammatory milieu of the gut.
HIV-1 infection causes relative reduction of total activated CD4
þ T cells and increase of total activated CD8 þ T cells in both the peripheral blood and gut mucosal compartments
Percentages of CD4 þ and CD8 þ subsets among all the T cells were assessed in persons with HIV-1 infection compared with uninfected control subjects. As expected, the CD4 þ T-cell percentage was lower in the infected group compared with the control group for both the gut and blood compartments ( Figure 3a ). This reduction was particularly marked for the CCR5-expressing subset vs. the HLA-DR-expressing subset in both the compartments (Figure 3b The concentrations of iNKT cells as percentages of total T cells in the gut and blood compartments were compared between the HIV-1-infected and control groups (Figure 4) . In the HIV-1-infected individuals, iNKT cells in both the compartments were not statistically different (Figure 4a) , while the balance of CD4 þ to CD4 À subsets of iNKT cells was skewed significantly in the gut but not in the blood (P ¼ 0.040 vs. P ¼ 1.000, Figure 4b ). This altered balance was mediated predominately by loss of the CD4 þ iNKT population, which was significantly depleted in the gut but not in the blood (P ¼ 0.005 vs. P ¼ 0.065, Figure 4c ). The same pattern of preferential depletion in the gut was seen when quantifying the CCR5 þ and HLA-DR þ subsets of these cells (P ¼ 0.004-0.028, Figure 4d ,e). By contrast, the CD4 À iNKT-cell subset was similar in frequency for HIV-1-infected and uninfected persons in both the compartments (Figure 4f-h ). In agreement with the susceptibility of CD4 þ iNKT cells to HIV-1 infection, 15, 18, 28 these data demonstrate preferential depletion of the anti-inflammatory CD4 þ iNKT cells in the gut compartment of HIV-1-infected persons, suggesting dysregulation in this pivotal immune reservoir.
Regulatory cytokine production by total CD4
þ T cells and iNKT-cell subsets are differentially affected by HIV-1 infection in the blood vs. gut compartments
The effects of HIV-1 infection on the capability of total CD4 þ T cells and iNKT-cell subsets to produce regulatory cytokines were examined in the blood and gut compartments ( Figure 5 ). As percentages of the total T-cell population, there was preservation of IFN-g-producing total CD4
þ T cells and iNKT-cell subsets in both the compartments (Figure 5a-c) . HIV-1 infection was associated with a net increase of IL-4-producing total CD4 þ T cells in the gut but not in the blood (P ¼ 0.040 and P ¼ 0.188, Figure 5d ). There was reduction of IL-4-producing CD4 þ iNKT cells in the blood with a potential trend for increase in the gut (P ¼ 0.020 and P ¼ 0.220, Figure 5e ) but no appreciable change in IL-4 production by the CD4 À iNKT-cell population (Figure 5f ). IL-17-producing CD4
þ T cells were decreased in the blood and not significantly reduced in the gut (P ¼ 0.030 and P ¼ 0.306, Figure 5g ), whereas there was undetectable production of this cytokine by either iNKT-cell subset (data not shown). Overall, these data demonstrate that Th1 pro-inflammatory function is preserved in the gut and blood after HIV-1 infection and that there may be an associated compensatory increase in Th2 activity in the gut in response to increased inflammation.
Activation and exhaustion of CD8
þ T cells in the gut are correlates of immune containment of HIV-1
Peripheral blood CD8
þ T cells have been found to exhibit correlations between activation or exhaustion with viremia, suggesting importance of the functional status of these cells in immune containment of infection. 29 The activation and exhaustion of CD8 þ T cells in the gut and blood compartments was compared with plasma viremia levels in the HIV-1-infected persons. The percentage of CD8 þ T cells expressing HLA-DR in either the gut or the blood were both positively correlated to viremia (P ¼ 0.007 and P ¼ 0.006, Figure 6a,d) , while the percentage expressing programmed cell death-1 in the gut was better correlated to viremia than that in the blood (P ¼ 0.048 and P ¼ 0.110, Figure 6b ,e). Moreover, CD4
þ iNKT-cell levels in the gut, but not in the blood, correlated negatively with viremia (P ¼ 0.024 and P ¼ 0.169, Figure 6c ,f), implying loss of these regulatory cells. These observations suggest that the crucial interactions between cellular immunity and HIV-1 may occur in the gut compartment rather than in the peripheral blood. 
Because CD4
þ and CD4 À iNKT-cell subpopulations are believed to have opposing roles in modulation of inflammation, we compared the balance (ratios) of these iNKT-cell subpopulations with activation and exhaustion of CD8 þ T cells in the HIV-1-infected persons. The CD4 þ to CD4 À ratio of iNKT cells in the gut correlated significantly to CD8 þ T-cell activation and exhaustion in the gut (P ¼ 0.037 and P ¼ 0.032, Figure 6g ,h) and blood (P ¼ 0.033 and P ¼ 0.054, Figure 6i,j) . By contrast, the ratio in the blood did not correlate to these CD8 þ T-cell parameters in either compartment (Figure 6k-n) . These data suggest that HIV-1-mediated iNKT perturbation in the gut rather than in the blood is a crucial contributor to the systemic immune activation that is the hallmark of HIV-1 pathogenesis.
DISCUSSION
This study is the first reported examination of iNKT-cell frequency, phenotype, and function in the gut lymphocyte compartment of HIV-1-infected persons. These cells have been studied in a variety of autoimmune and infectious diseases and are believed to have important roles in modulating adaptive immunity. Although previous studies of iNKT cells in the blood have demonstrated their susceptibility to HIV-1 infection and depletion in persons with HIV-1 infection, 15, [17] [18] [19] correlation of this finding to the pathogenesis of HIV-1 infection has been lacking. Our current study provides evidence that HIV-1-induced depletion of CD4 þ iNKT cells in the gut (but not in the blood) compartment has a pivotal role in the inappropriate immune activation that is the hallmark of disease progression to AIDS.
Physiologically an inflammatory environment rich in activated memory CD4 þ T cells and home to approximately 60% of total body lymphocytes, 21, 23 the gastrointestinal tract has been implicated as the key venue where HIV-1 infection begins in acute infection and causes immune damage, leading to disease progression in chronic infection. 30, 31 It has been proposed that generalized CD4 þ T-cell depletion in the gut during acute infection leads to ongoing microbial translocation from the gut to peripheral blood, resulting in chronic systemic immune activation that drives ongoing loss of CD4 þ T cells and disease progression in HIV-1 infection. 24, 25, 32 Although iNKT cells have been observed in the human 13, 33, 34 and murine [35] [36] [37] gut and one study has demonstrated that dysregulation of gut iNKT cells in humans can lead to disease (ulcerative colitis), 38 the impact of HIV-1 infection on this immune regulation in this compartment has been unexplored previously. Our data suggest that gut CD4 þ iNKT cells are depleted by HIV-1 infection and suggest an alternative (but not mutually exclusive) mechanism of increased immune activation in the gut.
At baseline in healthy persons, we find that the total iNKT-cell frequency is similar between blood and gut, while the CD4 þ subset is more prominent in the gut. Given the anti-inflammatory immunomodulatory properties of these cells, this is consistent with a Th2 regulatory role of CD4 þ iNKT cells in moderating the vigorous inflammation in this compartment. In HIV-1-infected persons, there is a relative loss of the CD4 þ iNKT subset (particularly those expressing CCR5) that is most pronounced in the gut compartment, consistent with the vulnerability of these cells to HIV-1 infection. 19 Although the remaining gut CD4 þ iNKT cells retain the capacity to produce IL-4, imbalance of CD4 þ vs. CD4 À iNKT cells is correlated to increased activation and exhaustion of the CD8 þ T cells systemically. This suggests that there is inadequate compensatory anti-inflammatory activity by these key regulatory cells in the gut after HIV-1 infection and that the degree to which the balance of CD4 þ vs. CD4 À iNKT cells is perturbed by HIV-1 infection in the gut (but not in the blood) is a key contributor to the inappropriate systemic immune activation driving HIV-1 pathogenesis.
A recent report regarding iNKT cells in Sooty Mangabeys lends additional support to this concept. 39 Rout et al. studied these natural hosts for Simian Immunodeficiency Virus (SIV), who have asymptomatic chronic infection and maintain high peripheral blood total CD4 þ T-cell levels despite high viremia. These animals do not exhibit the immune activation associated with progressive CD4 þ T-cell decline in the SIV-infected rhesus macaque model of AIDS. This study found that in contrast to rhesus macaques (and humans), Sooty Mangabeys lack CD4 þ iNKT cells but instead mediate anti-inflammatory effects via release of IL-10 by CD4 À iNKT cells. Thus, there is no perturbation of iNKT cells by SIV infection compared with rhesus macaques and humans who have CD4 þ and CCR5 þ iNKT cells. The Th17 axis has been implicated as being important for gut flora containment and suggested to be depressed in HIV-1 infection, resulting in microbial translocation and immune activation. 40 Although murine data have suggested that early thymic emigrant iNKT cells can produce IL-17, 41 this has not been observed in humans. 7 Our data substantiate activity of the Th17 axis in the bulk CD4 þ T cells of the gut compartment but not IL-17 production by iNKT cells. It is unclear, however, whether iNKT cells might produce IL-17 under other experimental conditions. 42 Moreover, while others have noted disruption of Th17 activity in the gut of persons with HIV-1 infection, 40, [43] [44] [45] [46] we detect its reduction in the blood but not in the gut compartments. Methodological differences or lack of sufficient power with our cohort may account for this discrepancy.
In summary, our data address an underlying mechanism for the systemic immune activation that characterizes HIV-1 infection and mediates progression of immunodeficiency. We observe that preferential loss of the CD4 þ iNKT cells in the gut but not in the blood compartment correlates with immune activation in both the gut and peripheral blood compartments, as measured by markers that are clinically predictive. Although it has been suggested that total CD4 þ Th cell depletion in the gut drives microbial translocation and systemic immune activation, 25, 47 our results provide an alternative explanation by suggesting that the key underlying defect may be immune dysregulation within the gut itself. This does not exclude a role for microbial translocation in this process, but it is unclear whether translocation is primarily involved or an epiphenomenon related to the iNKT-cell imbalance-mediated immune dysregulation. Overall, our observations reinforce the central importance of the gut compartment in HIV-1 pathogenesis and demonstrate a key immune regulatory defect in this major reservoir of T cells.
METHODS
Subjects. Caucasian men were studied to minimize potential variation due to race and gender. The 25 participants included 7 control seronegative and 18 chronically HIV-1-infected men with selfreported to have peripheral blood CD4 þ T lymphocyte counts 4300 cells ml À 1 without antiretroviral treatment for at least 6 months. Routine clinical laboratory testing of peripheral blood CD4
þ T cells and HIV-1 RNA was performed through the clinical laboratories at UCLA. All participants provided written informed consent under a University of California IRB-approved protocol. Demographics of these subjects are provided in Supplementary Table S1 online.
Mononuclear cell isolation. Peripheral blood mononuclear cells were isolated by Ficoll-Hypaque gradient centrifugation. Sigmoid colonic mucosal mononuclear cells were isolated as previously reported in detail. 48, 49 Briefly, 20 biopsies were obtained approximately 30 cm from the anal verge via flexible sigmoidoscopy using large-cup (3.3 mm) biopsy forceps. The biopsies were washed twice in RPMI 1640 medium with L-glutamine and HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), supplemented with 2.5 mg ml À 1 of amphotericin B (Fungione, GIBCO Invitrogen, Carlsbad, CA) and 0.1 mg ml À 1 of piperacillin-tazobactam (Zosyn, Lederle, Puerto Rico), and collagenase digested to obtain mononuclear cell suspensions, which were immediately stained and analyzed by flow cytometry. This typically yielded 2-5 million viable CD3 þ T cells per 17 processed biopsy samples, as assessed by flow cytometry using Trucount (BD Biosciences, San Jose, CA). Cell viability was consistently above 90% as assessed by trypan blue exclusion.
Cell phenotyping by surface markers. Flow cytometry was performed on freshly isolated mononuclear cells. The iNKT-cell population was defined by staining 0.5-2.0 Â 10 6 viable cells with saturating concentrations of anti-TCR Va24-phycoerythrin (PE), anti-TCR Vb11-fluorescein isothiocyanate (FITC), anti-CD3-peridinin chlorophyll protein (PerCP), anti-CD4-phycoerythrin-Cy7 (PECy7), and anti-CD8-allophycocyanin Cy-7 (APC-Cy7) for analysis on a FACSCanto flow cytometer (Becton Dickinson, San Jose, CA). Notably, staining for CD3, Va24, and Vb11 on lymphocytes has been shown to be highly sensitive and specific for iNKT cells, 50 which we confirmed in control experiments demonstrating 90% specificity of iNKT-cell identification using a combination of the monoclonal antibody 6B11 (specific for the iNKT-cell receptor) in conjunction with staining for CD3, Va24, and Vb11 (data not shown). Additional phenotyping was assessed by concomitant staining with allophycocyanin (APC)-labeled, anti-programmed cell death-1, anti-CCR5, or anti-HLA-DR antibodies. All monoclonal antibodies are delineated in Supplementary Table S2 online. Examples of the gating strategies are shown in Supplementary Figures S1 and 2 .
Assessment of cell function using intracellular cytokine analysis.
Peripheral blood mononuclear cells or mucosal mononuclear cells were incubated for 4 h at 37 1C in the presence of 25 ng ml À 1 of phorbol 12-myristate 13-acetate (Sigma, St Louis, MO), 1 mg ml À 1 of ionomycin (Sigma), BD GolgiStop (BD Biosciences), and 10 mg ml À 1 of Brefeldin A (Sigma). After two washes with phosphate-buffered saline containing 0.1% bovine serum albumin (0.1% BSA-PBS), the cells were stained for 15 min at room temperature with anti-TCR Va24-PE, anti-TCR Vb11-FITC, anti-CD3-PerCP, and anti-CD4-or anti-CD8-APC-Cy7. After a wash with 0.1% BSA-PBS, the cells were fixated and permeabilized using the Cytofix/Cytoperm Plus kit as recommended by the manufacturer (BD Biosciences). Cells were then incubated for 20 min at room temperature with anti-gamma interferon-phycoerythrin-Cy7 plus either anti-IL-4-or anti IL-17-APC, followed by washing and immediate analysis by flow cytometry. A minimum of 3 Â 10 5 cells per tube were analyzed. An example is show in Supplementary Figure S3 .
Statistical analyses. At least 5 Â 10 5 CD3 þ lymphocytes were collected through flow cytometry for all experiments. The nonparametric Mann-Whitney test was utilized for assessing differences between subpopulations. Pearson correlations were utilized for dot plots comparisons. Statistical analyses were carried out with Minitab Statistical Software (State College, PA). Statistical significance was defined as a P value of o0.05 for the null hypothesis.
